Evidence map›Paper›PMID 29280328›Full record

ReviewAdvanced healthcare materials2018

Recent Progress in Developing Injectable Matrices for Enhancing Cell Delivery and Tissue Regeneration.

Xinming Tong, Fan Yang

Abstract readReview
In one paragraph

Review in Advanced healthcare materials, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 29 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
29citing papers in PubMed, 1 pooled it
3.8field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

29 citing papers in PubMed, 1 synthesis or guideline pooled it, 71 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Article
  4. Review
  5. Hydrogels in Oral Disease Management: A Review of Innovations in Drug Delivery and Tissue Regeneration.Medical science monitor : international medical journal of experimental and clinical research · 2025
    Review
  6. Article
  7. Article
  8. Rational Design of Multifunctional Hydrogels for Wound Repair.Journal of functional biomaterials · 2023
    Review
  9. Review
  10. Article
  11. Application of injectable hydrogels in cancer immunotherapy.Frontiers in bioengineering and biotechnology · 2023
    Review
  12. Review
  13. Article
  14. Review
  15. Article
  16. Review
  17. Review
  18. [The research advances of three dimensional porous cryogel for tissue engineering].Sheng wu yi xue gong cheng xue za zhi = Journal of biomedical engineering = Shengwu yixue gongchengxue zazhi · 2021
    Review
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Xinming TongDepartment of Orthopaedic Surgery, Stanford University School of Medicine, Stanford, CA, 94305, USA.ORCID 0000-0001-7585-3866
Fan YangDepartment of Orthopaedic Surgery and Bioengineering, Stanford University School of Medicine, 300 Pasteur Dr., Edwards R105, Stanford, CA, 94305, USA.
Stanford University · US

Funding

Microribbon scaffold-mediated Immunomodulation for Cranial Bone RepairR01DE024772 · NIDCR · STANFORD UNIVERSITY · PI YANG, FAN · 2015 to 2025
$4.6M
NIDCR NIH HHS R01 DE024772
6 · The paper itself

Abstract

Biomaterials are key factors in regenerative medicine. Matrices used for cell delivery are especially important, as they provide support to transplanted cells that is essential for promoting cell survival, retention, and desirable phenotypes. Injectable matrices have become promising and attractive due to their minimum invasiveness and ease of use. Conventional injectable matrices mostly use hydrogel precursor solutions that form solid, cell-laden hydrogel scaffolds in situ. However, these materials are associated with challenges in biocompatibility, shear-induced cell death, lack of control over cellular phenotype, lack of macroporosity and remodeling, and relatively weak mechanical strength. This Progress Report provides a brief overview of recent progress in developing injectable matrices to overcome the limitations of conventional in situ hydrogels. Biocompatible chemistry and shear-thinning hydrogels have been introduced to promote cell survival and retention. Emerging investigations of the effects of matrix properties on cellular function in 3D provide important guidelines for promoting desirable cellular phenotypes. Moreover, several novel approaches are combining injectability with macroporosity to achieve macroporous, injectable matrices for cell delivery.

Indexed as

Biocompatible MaterialsCell TransplantationHydrogelsRegenerationAnimalsCells, ImmobilizedHumansRegenerative MedicineBiocompatible MaterialsHydrogelscell deliverycell therapyhydrogelsinjectablesmacroporoustissue regeneration

Identifiers

PMID29280328
PMCPMC6425976
OpenAlexW2776636750

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.